Risk factors for relapse and recurrence of depression in adults and how they operate: A four-phase systematic review and meta-synthesis

J E J Buckman, A Underwood, K Clarke, R Saunders, S D Hollon, P Fearon, S Pilling, J E J Buckman, A Underwood, K Clarke, R Saunders, S D Hollon, P Fearon, S Pilling

Abstract

Purpose: To review and synthesise prognostic indices that predict subsequent risk, prescriptive indices that moderate treatment response, and mechanisms that underlie each with respect to relapse and recurrence of depression in adults.

Results and conclusions: Childhood maltreatment, post-treatment residual symptoms, and a history of recurrence emerged as strong prognostic indicators of risk and each could be used prescriptively to indicate who benefits most from continued or prophylactic treatment. Targeting prognostic indices or their "down-stream" consequences will be particularly beneficial because each is either a cause or a consequence of the causal mechanisms underlying risk of recurrence. The cognitive and neural mechanisms that underlie the prognostic indices are likely addressed by the effects of treatments that are moderated by the prescriptive factors. For example, psychosocial interventions that target the consequences of childhood maltreatment, extending pharmacotherapy or adapting psychological therapies to deal with residual symptoms, or using cognitive or mindfulness-based therapies for those with prior histories of recurrence. Future research that focuses on understanding causal pathways that link childhood maltreatment, or cognitive diatheses, to dysfunction in the neocortical and limbic pathways that process affective information and facilitate cognitive control, might result in more enduring effects of treatments for depression.

Keywords: Depression; Depressive disorder; Major; Recurrence; Review; Risk factors.

Copyright © 2018 The Authors. Published by Elsevier Ltd.. All rights reserved.

Figures

Fig. 1
Fig. 1
Forest plots from Generic Inverse-Variance meta-analyses of prognostic risk factors for relapse or recurrence of depression.
Fig. 1
Fig. 1
Forest plots from Generic Inverse-Variance meta-analyses of prognostic risk factors for relapse or recurrence of depression.
Fig. 2
Fig. 2
Conceptual Framework: Prognostic and prescriptive factors and their interaction with mechanisms of relapse and recurrence of depression in adults.

References

    1. Andrews P.W., Kornstein S.G., Halberstadt L.J., Gardner C.O., Neale M.C. Blue again: Perturbational effects of antidepressants suggest monoaminergic homeostasis in major depression. Frontiers in Psychology. 2011;2:1–24.
    1. Andrews P.W., Thomson J.A., Amstadter A., Neale M.C. Primum non-nocere: An evolutionary analysis of whether antidepressants do more harm than good. Frontiers in Psychology. 2012;3:1–19.
    1. Angst J., Kupfer D.J., Rosenbaum J.F. Recovery from depression: Risk or reality? Acta Psychiatrica Scandinavica. 1996;93:413–419.
    1. Arnone D., McKie S., Juhasz G., Thomas E.J., Downey D., Williams S. State-dependent changes in hippocampal grey matter in depression. Molecular Psychiatry. 2012;18:1265–1272.
    1. Baldessarini R.J., Forte A., Selle V., Sim K., Tondo L., Undurraga J., Vázquez G.H. Morbidity in depressive disorders. Psychotherapy and Psychosomatics. 2017;86:65–72.
    1. Beckerman N., Corbett L. Mindfulness and cognitive therapy in depression relapse prevention: A case study. Clinical Social Work Journal. 2010;38:217–225.
    1. Berwian I.M., Walter H., Seifritz E., Huys Q.J.M. Predicting relapse after antidepressant withdrawal–a systematic review. Psychological Medicine. 2017;47:426–437.
    1. Beshai S., Dobson K.S., Bockting C.L.H., Quigley L. Relapse and recurrence prevention in depression: Current research and future prospects. Clinical Psychology Review. 2011;31:1349–1360.
    1. Bockting C.L., Schene A.H., Spinhoven P., Koeter M.W., Wouters L.F., Huyser J., Kamphuis J.H. Preventing relapse/recurrence in recurrent depression with cognitive therapy: A randomized controlled trial. Journal of Consulting and Clinical Psychology. 2005;73:647.
    1. Bockting C.L., Spinhoven P., Koeter M.W., Wouters L.F., Visser I., Schene A.H. Differential predictors of response to preventive cognitive therapy in recurrent depression: A 2-year prospective study. Psychotherapy and Psychosomatics. 2006;75:229–236.
    1. Bockting C.L., Spinhoven P., Wouters L.F., Koeter M.W., Schene A.H. Long-term effects of preventive cognitive therapy in recurrent depression: A 5.5-year follow-up study. Journal of Clinical Psychiatry. 2009;16:1621.
    1. Bos E.H., Bouhuys A.L., Geerts E., van Os T.W., Ormel J. Stressful life events as a link between problems in nonverbal communication and recurrence of depression. Journal of Affective Disorders. 2007;97:161–169.
    1. Bourgon L.N., Kellner C.H. Relapse of depression after ECT: A review. The Journal of ECT. 2000;16:19–31.
    1. Bower P., Kontopantelis E., Sutton A., Kendrick T., Richards D.A., Gilbody S.…Meyer B. Influence of initial severity of depression on effectiveness of low intensity interventions: Meta-analysis of individual patient data. British Medical Journal. 2013;346:f540.
    1. Burcusa S.L., Iacono W.G. Risk for recurrence in depression. Clinical Psychology Review. 2007;27:959–985.
    1. Campbell R.J. 9th ed. Oxford University Press; New York: 2009. Campbell's psychiatric dictionary.
    1. Carvalho A.F., Sharma M.S., Brunoni A.R., Vieta E., Fava G.A. The safety, tolerability and risks associated with the use of newer generation antidepressant drugs: A critical review of the literature. Psychotherapy and Psychosomatics. 2016;85:270–288.
    1. Castaneda A.E., Suvisaari J., Marttunen M., Perälä J., Saarni S.I., Aalto-Setälä T. Cognitive functioning in a population-based sample of young adults with a history of non-psychotic unipolar depressive disorders without psychiatric comorbidity. Journal of Affective Disorders. 2008;110:36–45.
    1. Chen J., Ma W., Wu X., Wei D., Liu G., Deng Z. Distinct facial processing related negative cognitive Bias in first-episode and recurrent major depression: Evidence from the N170 ERP component. PLoS One. 2014;9
    1. Chen J., Zhang W., Wei D., Wu X., Fu Q., Xu F. Neurophysiological handover from MMN to P3a in first-episode and recurrent major depression. Journal of Affective Disorders. 2015;174:173–179.
    1. Clarke K., Mayo-Wilson E., Kenny J., Pilling S. Can non-pharmacological interventions prevent relapse in adults who have recovered from depression? A systematic review and meta-analysis of randomised controlled trials. Clinical Psychology Review. 2015;39:58–70.
    1. Cochrane T.C. The Nordic Cochrane Centre; Copenhagen: 2008. Review manager (RevMan) 5.3.
    1. Coleman K., Norris S., Weston A., Grimmer-Somers K., Hillier S., Merlin T. NHMRC; Canberra: 2005. NHMRC additional levels of evidence and grades for recommendations for developers of guidelines.
    1. Conradi H.J., de Jonge P., Ormel J. Prediction of the three-year course of recurrent depression in primary care patients: Different risk factors for different outcomes. Journal of Affective Disorders. 2008;105:267–271.
    1. Cuijpers P., Hollon S.D., van Straten A., Bockting C., Berking M., Andersson G. Does cognitive behaviour therapy have an enduring effect that is superior to keeping patients on continuation pharmacotherapy? A meta-analysis. BMJ Open. 2013;3
    1. DerSimonian R., Laird N. Meta-analysis in clinical trials. Controlled Clinical Trials. 1986;7:177–188.
    1. Dijkstra-Kersten S.M., Sitnikova K., Terluin B., Penninx B.W., Twisk J.W., van Marwijk H.W.…van der Wouden J.C. Longitudinal associations of multiple physical symptoms with recurrence of depressive and anxiety disorders. Journal of Psychosomatic Research. 2017;97:96–101.
    1. Disner S.G., Beevers C.G., Haigh E.A.P., Beck A.T. Neural mechanism of the cognitive model of depression. Nature Reviews Neuroscience. 2011;12:467–477.
    1. Dobson K.S., Hollon S.D., Dimidjian S., Schmaling K.B., Kohlenberg R.J., Gallop R.J.…Jacobson N.S. Randomized trial of behavioral activation, cognitive therapy, and antidepressant medication in the prevention of relapse and recurrence in major depression. Journal of Consulting and Clinical Psychology. 2008;76:468.
    1. Dreyer N.A., Velentgas P., Westrich K., Dubois R. The GRACE checklist for rating the quality of observational studies of comparative effectiveness: A tale of hope and caution. Journal of Managed Care Pharmacy. 2014;20:301–308.
    1. Eaton W.W., Shao H., Nestadt G., Lee B.H., Bienvenu O.J., Zandi P. Population-based study of first onset and chronicity in major depressive disorder. Archives of General Psychiatry. 2008;65:513–520.
    1. Elgersma H.J., Glashouwer K.A., Bockting C.L., Penninx B.W., de Jong P.J. Hidden scars in depression? Implicit and explicit self-associations following recurrent depressive episodes. Journal of Abnormal Psychology. 2013;122:951.
    1. Farb N.A.S., Irving J.A., Anderson A.K., Segal Z.V. A two-factor model of relapse/recurrence vulnerability in unipolar depression. Journal of Abnormal Psychology. 2015;124:38–55.
    1. Faul F., Erdfelder E., Lang A.-G., Buchner A. G*power 3: A flexible statistical power analysis program for the social, behavioural, and biomedical sciences. Behavior Research Methods. 2007;39:175–191.
    1. Fava G.A. Can long-term treatment with antidepressant drugs worsen the course of depression? Journal of Clinical Psychiatry. 2003;64:123–133.
    1. Fava G.A., Rafanelli C., Grandi S., Canestrari R., Morphy M.A. Six-year outcome for cognitive behavioral treatment of residual symptoms in major depression. American Journal of Psychiatry. 1998;155:14–43.
    1. Feng C.Y., Chu H., Chen C.H., Chang Y.S., Chen T.H., Chou Y.H. The effect of cognitive behavioural group therapy for depression: A meta-analysis 2000–2010. World Views on Evidence-Based Nursing. 2012;9:2–17.
    1. Fournier J.C., Derubeis R.J., Shelton R.C., Hollon S.D., Amsterdam J.D., Gallop R. Prediction of response to medication and cognitive therapy in the treatment of moderate to severe depression. Journal of Consulting and Clinical Psychology. 2009;77:775.
    1. Francke A.L., Smit M.C., de Veer A.J., Mistiaen P. Factors influencing the implementation of clinical guidelines for health care professionals: A systematic meta-review. BMC Medical Informatics and Decision Making. 2008;8:38.
    1. Frank E., Prien R.F., Jarrett R.B., Keller M.B., Kupfer D.J., Lavori P.W. Conceptualization and rationale for consensus definitions of terms in major depressive disorder: Remission, recovery, relapse, and recurrence. Archives of General Psychiatry. 1991;48:851–855.
    1. Gelder M.G., Lopez-Ibor J.J., Andreasen N.C. Oxford University Press; New York: 2000. New Oxford textbook of psychiatry.
    1. Gerrits M.M., van Oppen P., Leone S.S., van Marwijk H.W., van der Horst H.E., Penninx B.W. Pain, not chronic disease, is associated with the recurrence of depressive and anxiety disorders. BMC Psychiatry. 2014;14:187.
    1. Gopinath S., Katon W.J., Russo J.E., Ludman E.J. Clinical factors associated with relapse in primary care patients with chronic or recurrent depression. Journal of Affective Disorders. 2007;101:57–63.
    1. Gueorguieva R., Chekroud A.M., Krystal J.H. Trajectories of relapse in randomised, placebo-controlled trials of treatment discontinuation in major depressive disorder: An individual patient-level data meta-analysis. The Lancet Psychiatry. 2017;4:230–237.
    1. Guidi J., Tomba E., Fava G.A. The sequential integration of pharmacotherapy and psychotherapy in the treatment of major depressive disorder: A meta-analysis of the sequential model and a critical review of the literature. American Journal of Psychiatry. 2015;173:128–137.
    1. Guyatt G.H., Oxman A.D., Vist G.E., Kunz R., Falck-Ytter Y., Alonso-Coello P. GRADE: An emerging consensus on rating quality of evidence and strength of recommendations. British Medical Journal. 2008;26:924–926.
    1. Hardeveld F., Spijker J., De Graaf R., Nolen W.A., Beekman A.T.F. Prevalence and predictors of recurrence of major depressive disorder in the adult population. Acta Pyschiatrica Scandinavica. 2010;122:184–191.
    1. Hardeveld F., Spijker J., De Graaf R., Hendriks S.M., Licht C.M., Nolen W.A.…Beekman A.T. Recurrence of major depressive disorder across different treatment settings: Results from the NESDA study. Journal of Affective Disorders. 2013;147:225–231.
    1. Hardeveld F., Spijker J., De Graaf R., Nolen W.A., Beekman A.T.F. Recurrence of major depressive disorder and its predictors in the general population: Results from the Netherlands mental health survey and incidence study (NEMESIS) Psychological Medicine. 2013;43:39–48.
    1. Hardeveld F., Spijker J., Vreeburg S.A., De Graaf R., Hendriks S.M., Licht C.M.…Beekman A.T. Increased cortisol awakening response was associated with time to recurrence of major depressive disorder. Psychoneuroendocrinology. 2014;50:62–71.
    1. Hardeveld F., Spijker J., Peyrot W.J., de Graaf R., Hendriks S.M., Nolen W.A.…Beekman A.T. Glucocorticoid and mineralocorticoid receptor polymorphisms and recurrence of major depressive disorder. Psychoneuroendocrinology. 2015;55:154–163.
    1. Higgins J.P.T., Green S., editors. Cochrane handbook for systematic reviews of interventions. John Wiley & Sons; Chichester (UK): 2008.
    1. Hollon S.D., Thase M.E., Markowitz J.C. Treatment and prevention of depression. Psychological Science in the Public Interest. 2002;3:39–77.
    1. Hollon S.D., Derubeis R.J., Shelton R.C., Amsterdam J.D., Salomon R.M., O'Reardon J.P.…Gallop R. Prevention of relapse following cognitive therapy vs medications in moderate to severe depression. Archives of General Psychiatry. 2005;62:417–422.
    1. Holma K.M., Holma I.A., Melartin T.K., Rytsälä H.J., Isometsä E.T. Long-term outcome of major depressive disorder in psychiatric patients is variable. The Journal of Clinical Psychiatry. 2008;69:196–205.
    1. Hughes S., Cohen D. A systematic review of long-term studies of drug treated and non-drug treated depression. Journal of Affective Disorders. 2009;118:9–18.
    1. Ilardi S.S., Craighead W.E., Evans D.D. Modeling relapse in unipolar depression: The effects of dysfunctional cognitions and personality disorders. Journal of Consulting and Clinical Psychology. 1997;65:381.
    1. Innovative Medicines Initiative 2018. RADAR-CNS Remote Assessment of Disease and Relapse in Central Nervous System Disorders. Retrieved June 6, 2017 n. d. from .
    1. Judd L.J. The clinical course of unipolar major depressive disorders. Archives of General Psychiatry. 1997;54:989–991.
    1. Judd L.L., Akiskal H.S., Maser J.D., Zeller P.J., Endicott J., Coryell W.…Rice J.A. Major depressive disorder: A prospective study of residual subthreshold depressive symptoms as predictor of rapid relapse. Journal of Affective Disorders. 1998;50:97–108.
    1. Kanai T., Takeuchi H., Furukawa T.A., Yoshimura R., Imaizumi T., Kitamura T., Takahashi K. Time to recurrence after recovery from major depressive episodes and its predictors. Psychological Medicine. 2003;33:839–845.
    1. Kazdin A.E. Mediators and mechanisms of change in psychotherapy research. Annual Review of Clinical Psychology. 2007;3:1–27.
    1. Kennedy N., Paykel E.S. Residual symptoms at remission from depression: Impact on long-term outcome. Journal of Affective Disorders. 2004;80:135–144.
    1. Kessler R.C., Wang P.S. The epidemiology of depression. In: Gotlib I.H., Hammen C.L., editors. Handbook of depression 2. Guilford Press; New York: 2009. pp. 5–22.
    1. Kessler R.C., Berglund P., Demler O., Jin R., Koretz D., Merikangas K.R.…Wang P.S. The epidemiology of major depressive disorder: Results from the National Comorbidity Survey Replication (NCS-R) Journal of the American Medical Association. 2003;289:3095–3105.
    1. Kmet L.M., Lee R.C., Cook L.S. Alberta Heritage Foundation for Medical Research; Edmonton, CA: 2004. Standard quality assessment criteria for evaluating primary research papers from a variety of fields.
    1. Kok G.D., Bockting C.L.H., Burger H., Hannig W., Pijenborg G.H.M., Cuijpers P. Double trouble: Does co-morbid chronic somatic illness increase risk for recurrence in depression? A systematic review. PLoS One. 2013;8
    1. Kronmuller K.-T., Pantel J., Kohler S., Victor D., Giesel F., Magnotta V.A. British Journal of Psychiatry. 2008;192:472–473.
    1. Lin E.H., Katon W.J., Vonkorff M., Russo J.E., Simon G.E., Bush T.M.…Ludman E. Relapse of depression in primary care: Rate and clinical predictors. Archives of Family Medicine. 1998;7:443.
    1. Lorenzo-Luaces L. Heterogeneity in the prognosis of major depression: From the common cold to a highly debilitating and recurrent illness. Epidemiology and Psychiatric Sciences. 2015;24:466–472.
    1. Lythe K.E., Moll J., Gethin J.A., Workman C.I., Green S., Ralph M.A.L.…Zahn R. Self-blame–selective hyperconnectivity between anterior temporal and subgenual cortices and prediction of recurrent depressive episodes. JAMA Psychiatry. 2015;72:1119–1126.
    1. Melartin T.K., Rytsala H.J., Leskela U.S., Lestela-Mielonen P.S., Sokero T.P., Isometsa E.T. Severity and comorbidity predict episode duration and recurrence of DSM-IV major depressive disorder. Journal of Clinical Psychiatry. 2004;65:810–819.
    1. Moher D., Liberati A., Tetzlaff J., Altman D.G. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Medicine. 2009;6
    1. Monroe S.M., Harkness K.L. Life stress, the “kindling” hypothesis, and the recurrence of depression: Considerations from a life stress perspective. Psychological Review. 2005;112:417–445.
    1. Monroe S.M., Harkness K.L. Recurrence in major depression: A conceptual analysis. Psychological Review. 2011;118:655–674.
    1. Mueller T.I., Leon A.C., Keller M.B., Solomon D.A., Endicott J., Coryell W. Recurrence after recovery from major depressive disorder during 15 years of observational follow-up. American Journal of Psychiatry. 1999;156:1000–1006.
    1. Nanni V., Uher R., Danese A. Childhood maltreatment predicts unfavourable course of illness and treatment outcome in depression: A meta-analysis. American Journal of Psychiatry. 2012;169:141–151.
    1. Nixon N.L., Liddle P.F., Worwood G., Liotti M., Nixon E. Prefrontal cortex function in remitted major depressive disorder. Psychological Medicine. 2013;43:1219–1230.
    1. Paykel E.S. Partial remission, residual symptoms, and relapse in depression. Dialogues in Clinical Neuroscience. 2008;10:431.
    1. Paykel E.S., Priest R.G. Recognition and management of depression in general practice: Consensus statement. British Medical Journal. 1992;305:1198–1202.
    1. Paykel E.S., Scott J., Teasdale J.D., Johnson A.L., Garlan A., Moore R. Prevention of relapse in residual depression by cognitive therapy. Archives of General Psychiatry. 1999;56:829–839.
    1. Prince M., Patel V., Saxena S., Maj M., Maselko J., Phillips M.R. No health without mental health. Lancet. 2007;370:859–877.
    1. Reimherr F.W., Amsterdam J.D., Quitkin F.M., Rosenbaum J.F., Fava M., Zajecka J.…Sundell K. Optimal length of continuation therapy in depression: A prospective assessment during long-term fluoxetine treatment. American Journal of Psychiatry. 1998;155:1247–1253.
    1. Risch A.K., Buba A., Birk U., Morina N., Steffens M., Stangier U. Implicit self-esteem in recurrently depressed patients. Journal of Behavior Therapy and Experimental Psychiatry. 2010;41:199–206.
    1. Rohde P., Lewinsohn P.M., Klein D.N., Seeley J.R., Gau J.M. Key characteristics of major depressive disorder occurring in childhood, adolescence, emerging adulthood, and adulthood. Clinical Psychological Science. 2013;1:41–53.
    1. Roiser J.P., Elliot E., Sahakian B.J. Cognitive mechanisms of treatment in depression. Neuropsychopharmacology. 2012;37:117–136.
    1. Rush A.J., Kraemer H.C., Sackeim H.A., Fava M., Trivedi M.H., Frank E.…Regier D.A. Report by the ACNP task force on response and remission in major depressive disorder. Neuropsychopharmacology. 2006;31:1841–1853.
    1. Segal Z.V., Kennedy S., Gemar M., Hood K., Pedersen R., Buis T. Cognitive reactivity to sad mood provocation and the prediction of depressive relapse. Archives of General Psychiatry. 2006;63:749–755.
    1. Serra-Blasco M., Diego-Adeliño J., Vives-Gilabert Y., Trujols J., Puigdemont D., Carceller-Sindreu M.…Portella M.J. Naturalistic course of major depressive disorder predicted by clinical and structural neuroimaging data: A 5-year follow-up. Depression and Anxiety. 2016;33:1055–1064.
    1. Shea B.J., Grimshaw J.M., Wells G.A., Boers M., Andersson N., Hamel C. Development of AMSTAR: A measurement tool to assess the methodological quality of systematic reviews. BMC Medical Research Methodology. 2007;7:10–17.
    1. Solomon D.A., Keller M.B., Leon A.C., Mueller T.I., Lavori P.W., Shea M.T.…Endicott J. Multiple recurrences of major depressive disorder. American Journal of Psychiatry. 2000;157:229–233.
    1. Spinhoven P., Drost J., de Rooij M., van Hemert A.M., Penninx B.W. Is experiential avoidance a mediating, moderating, independent, overlapping, or proxy risk factor in the onset, relapse and maintenance of depressive disorders? Cognitive Therapy and Research. 2016;40:150–163.
    1. Thase M.E. Preventing relapse and recurrence of depression: A brief review of therapeutic options. CNS Spectrums. 2006;11:12–21.
    1. Wang J.L., Patten S., Sareen J., Bolton J., Schmitz N., MacQueen G. Development and validation of a prediction algorithm for use by health professionals in prediction of recurrence of major depression. Depression and Anxiety. 2014;31:451–457.
    1. Watkins E.D., Baracaia S. Rumination and social problem solving in depression. Behaviour Research and Therapy. 2002;40:1179–1189.
    1. Williams J.M.G., Crane C., Barnhofer T., Brennan K., Duggan D.S., Fennell M.J.…Shah D. Mindfulness-based cognitive therapy for preventing relapse in recurrent depression: A randomized dismantling trial. Journal of Consulting and Clinical Psychology. 2014;82:275.

Source: PubMed

Szponzorok és közreműködők

Egészségi állapot

Kábítószer-beavatkozások

3
Iratkozz fel